These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 15897467)

  • 21. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
    Kuba K; Imai Y; Rao S; Gao H; Guo F; Guan B; Huan Y; Yang P; Zhang Y; Deng W; Bao L; Zhang B; Liu G; Wang Z; Chappell M; Liu Y; Zheng D; Leibbrandt A; Wada T; Slutsky AS; Liu D; Qin C; Jiang C; Penninger JM
    Nat Med; 2005 Aug; 11(8):875-9. PubMed ID: 16007097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus.
    Xu L; Zhang Y; Liu Y; Chen Z; Deng H; Ma Z; Wang H; Hu Z; Deng F
    J Gen Virol; 2009 Nov; 90(Pt 11):2695-2703. PubMed ID: 19625462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
    Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
    Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
    Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells.
    Milewska A; Zarebski M; Nowak P; Stozek K; Potempa J; Pyrc K
    J Virol; 2014 Nov; 88(22):13221-30. PubMed ID: 25187545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronaviruses and SARS-COV-2.
    Hasöksüz M; Kiliç S; Saraç F
    Turk J Med Sci; 2020 Apr; 50(SI-1):549-556. PubMed ID: 32293832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.
    Huang IC; Bosch BJ; Li W; Farzan M; Rottier PM; Choe H
    Adv Exp Med Biol; 2006; 581():335-8. PubMed ID: 17037556
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of human coronavirus NL63 infection and replication.
    Castillo G; Mora-Díaz JC; Breuer M; Singh P; Nelli RK; Giménez-Lirola LG
    Virus Res; 2023 Apr; 327():199078. PubMed ID: 36813239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
    Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
    J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.
    Sastre P; Dijkman R; Camuñas A; Ruiz T; Jebbink MF; van der Hoek L; Vela C; Rueda P
    Clin Vaccine Immunol; 2011 Jan; 18(1):113-8. PubMed ID: 21084464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
    Otter CJ; Fausto A; Tan LH; Khosla AS; Cohen NA; Weiss SR
    Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2218083120. PubMed ID: 37023127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
    Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
    Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.
    Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C
    Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
    Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
    Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.